百濟神州(06160.HK):百澤安聯合化療3期臨床試驗取得積極結果
百濟神州(06160.HK)公布,其研發的百澤安聯合化療,對比安慰劑聯合化療用於一線治療局部晚期、不可切除或轉移性胃或胃食管結合部腺癌患者的全球3期臨床試驗RATIONALE 305取得積極結果。
公司指,在期中分析中,百澤安聯合化療在表達PD-L1的患者中達到了總生存期的主要終點,需進一步隨訪以評估意向治療患者人群的總生存期獲益。百澤安的安全性結果與此前試驗中的觀察一致,與化療聯用未出現新的安全性警示。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.